An immune risk phenotype, cognitive impairment, and survival in very late life: Impact of allostatic load in Swedish octogenarian and nonagenarian humans

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 5, 2005, Pages 556-565

  Wikby, Anders ^a   Ferguson, Frederick ^b   Forsey, Rosalyn ^c   Thompson, Julie ^c   Strindhall, Jan ^a   Löfgren, Sture ^d   Nilsson, Bengt Olof ^d   Ernerudh, Jan ^e   Pawelec, Graham ^f   Johansson, Boo ^a,g  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNILEVER RESEARCH   (United Kingdom)

^d University Teaching Hospital Ryhov   (Sweden)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; INTERLEUKIN 2; INTERLEUKIN 6;

AGED; AGING; ARTICLE; CELL DIFFERENTIATION; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; IMMUNOASSAY; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; STRESS; SURVIVAL; SWEDEN; T LYMPHOCYTE; VIRUS INFECTION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4;

EID: 20544476197     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.5.556     Document Type: Article

References (56)

1. McEwen BS, Stellar E. Stress and the individual: mechanism leading to disease. Arch Int Med. 1993;153:2093-2101.
2. McEwen BS. Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism. 2003;52:10-16.
3. Murasko DM, Weiner P, Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol. 1987;70:440-448.
4. Roberts-Thomson IC, Wittingham S, Youngchaiyud U, Mackay IR. Ageing, immune response and mortality. Lancet. 1974;2:368-370.
5. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol Biol Sci Med Sci. 1990;45A:M45-M48.
6. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol Biol Sci. 1995;50A:B378-B382.
7. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev. 1998;102:187-198.
8. Huppert FA, Pinto EM, Morgan K, Brayne C. Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech Ageing Dev. 2003;124:449-451.
9. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev. 2000;121:187-201.
10. Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol. 2002;37:445-453.
11. Hamann D, Roos MT, van Lier RA. Faces and phases of human CD8 T-cell development. Immunol Today. 1999;20:177-180.
12. Tomiyama H, Matsuda T, Takiguchi M. Differentiation of human CD8+ cells from a memory to memory/effector phenotype. J Immunol. 2002;168:5538-5550.
13. Wills MR, Okecha G, Weekes MP, Gandhi MK, Sissons PJ, Carmichael AJ. Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T-cell response. J Immunol. 2002;168:5455-5464.
14. van Baarle D, Kostense S, van Oers MHJ, Hamann D, Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol. 2002;23:586-591.
15. Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94-96.
16. Appay V, Dunbar PR, Callin M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-385.
17. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15:365-375.
18. Wilson RS, Beckett LA, Bienias JL, Evans DA, Bennet DA. Terminal decline in cognitive function. Neurology. 2003;60:1782-1787.
19. Johansson B, Zarit SH. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry. 1997;12:53-59.
20. Nybo H, Petersen HC, Gaist D, et al. Predictors of mortality in 2249 nonagenarians: the Danish 1905 Cohort Survey. J Am Geriatr Soc. 2003;51:1365-1373.
21. Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition: the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002;50:2041-2056.
22. Tarkowski E. Cytokines in dementias. Curr Drug Targets Inflamm Allergy. 2002;1:193-200.
23. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421.
24. Johansson B, Zarit SH, Berg S. Changes in cognitive functioning of the oldest old. J Gerontol Psychol Sci. 1992;47:P75-P80.
25. Wikby A, Johansson B, Ferguson F, Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol. 1994;29:531-541.
26. Nilsson BO, Ernerudh J, Johansson B, et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev. 2003;124:469-476.
27. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
28. Johansson B. The MIR-Memory in Reality Test. Stockholm, Sweden: Psykologiförlaget AB; 1988/89.
29. Karlamangla AS, Singer BH, McEven BS, Rowe JW, Seeman TE. Allostatic load as a predictor of functional decline: MacArthur studies of successful aging. J Clin Epidemiol. 2002;55:696-710.
30. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43:2-15.
31. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J Immunol. 1995;155:5046-5056.
32. + T cell clones in elderly humans. J Immunol. 1997;158:4493-4499.
33. Mugniani EN, Egeland T, Spurkland A, Brinchmann JE. The T-cell receptor repertoire of CD8+CD28- T-lymphocytes is dominated by expanded clones that persist over time. Clin Exp Immunol. 1999;117:298-303.
34. - cytotoxic effector clones. Int Immunol. 1999;11:229-241.
35. Weekes MP, Wills MR, Mynard K, Carmichael AJ, Sissons JGP. The memory cytotoxic T lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol. 1999;73:2099-2108.
36. Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JGP. Human CD28-CD8+ T-cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol. 1999;162:7569-7577.
37. Ricalton NS, Roberton C, Norris JM, Rewers M, Hamman RF, Kotzin BL. Prevalence of CD8+ T cell expansion in relation to age in healthy individuals. J Gerontol Biol Sci. 1998;53A:B196-B203.
38. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-1992.
39. Ouyang Q, Wagner WM, Wikby A, et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol. 2003;23:247-257.
40. LeMaoult J, Messaoudi I, Manavalan JS, et al. Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J Immunol. 2000;165:2367-2373.
41. Wikby A, Johansson B, Ferguson F. The OCTO and NONA immune longitudinal studies: a review of 11 years studies of Swedish very old humans. Adv Cell Aging Gerontol. 2003;13:1-16.
42. Papagno L, Spina CA, Marchant A, et al. Immune activation and CD8(+) T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004;2:E20.
43. Pawelec G, Akbar A, Caruso C, Effros R, Glubeck-Loebenstein B, Wikby A. Is immunosenescence infectious? Trends Immunol. 2004;25:406-410.
44. Trzonkowski P, Mysliwska J, Szmit E, et al. Associations between cytomegalovirus infection, enhanced proinflammatory response and low levels of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine. 2003;21:3826-3836.
45. Saurwein-Teissl M, Lung TL, Marx F, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol. 2002;168:5893-5899.
46. Goronzy JJ, Fulbright JW, Crowson CS, et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 2001;75:12182-12187.
47. Ouyang Q, Wagner WM, Walter S, et al. An age-related increase in the number of CD8(+) T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev. 2003;124:477-485.
48. EIrefaei M, El-Sheikh N, Kamal K, Cao H. HCV-specific CD27-CD28- memory T cells are depleted in hepatitis C virus and Schistosoma mansoni co-infection. Immunology. 2003;110:513-518.
49. Forsey RJ, Thompson JM, Ernerudh J, et al. Plasma cytokine profiles in elderly humans. Mech Ageing Dev. 2003;124:487-493.
50. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging. Neurology. 2002;59:371-378.
51. Trieb K, Ransmayr G, Sgonc R, Lassmann H, Grubeck-Loebenstein B. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol Aging. 1996;17:541-547.
52. Song DK, Im YB, Jung JS, Cho J, Suh HW, Kim YH. Central beta-amyloid peptide-induced peripheral interleulin-6 responses in mice. J Neurochem. 2001;76:1326-1335.
53. Sala G, Galimberti G, Canvari C, et al. Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiol Aging. 2003;24:909-914.
54. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine Il-6. Proc Natl Acad Sci U S A. 2003;100:9090-9095.
55. Francavilla V, Accapezzato D, De Salvo M, et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms. Eur J Immunol. 2004;34:427-437.
56. Mastorakos G, Chrousos GP, Weber JS. Recombinant Il-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 1993;77:1690-1694.